Percutaneous mitral commissurotomy: Difference between revisions

Jump to navigation Jump to search
 
Line 1: Line 1:
__NOTOC__
#Redirect [[Percutaneous mitral balloon commissurotomy]]
{{SI}}
{{CMG}}; Joanna J. Wykrzykowska, M.D.
 
==Percutaneous Mitral Commissurotomy==
====Patient selection====
#Mitral stenosis due to rheumatic disease is becoming less common in the US but is very prevalent worldwide
#Symptoms of shortness of breath and valve area or less than 1.5 cm2 are indications for commissurotomy
#Unlike with the surgical approach, elevated pulmonary pressures or depressued LV function are not contraindications
#Wilkins score that describes valve anatomy is the best predictor of procedural success: it assigns points for leaflet mobility, valvular and subvulvular thickening and calcification degree (score of < 8 makes the patient a favorable candidate); Thus good quality echocardiogram is essential before qualifying the patient for the procedure
#Contraindications include presence of left atrial appendage clot, moderate to severe mitral regurgitation or other indications for open heart surgery
 
====Technique====
#Transvenous transeptal technique is most commonly used with the Inoue balloon system
#Fossa ovalis lies usually at 1-7 o’clock but this orientation can be distorted in the presence of mitral stenosis where the interatrial septum becomes more flat, horizontal and lower
#For the femoral vein approach a 70 cm Brockenbrough needle should be used or an 8 Fr Mullins sheath and advanced under fluoroscopic guidance with pressure monitoring
#The latter is necessary to monitor for puncture into adjacent structures such as aorta
#Further catheter manipulation may be necessary to direct the catheter into the left ventricle through the mitral valve rather than towards one of the pulmonary veins
#Mullins sheath is exchanged for a solid-core coiled 0.025 inch guidewire over which a 14 Fr dilator is placed
#This is exchanged for the Inoue balloon (24-30 mm) which inflates in three stages allowing for balloon self-positioning with the last inflation resulting in commisural splitting
 
====Outcomes====
#Results of the commisurotomy should be assessed with hemodynamics and echocardiography
#If second inflation is needed mitral regurgitation should be assessed
#In general increasing valve area to greater than 1 cm2/m2 is an acceptable result
#Usually the valve area doubles and the pulmonary pressures degrease immediately
#5 year survival is in the 90% range
 
====Complications====
#Usually less than 5% with low mortality
#Failure to puncture the interatrial septum is the most common reason for aborted procedure
#Most common complication is development of severe mitral regurgitation   
 
==2008 and Incorporated 2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease (DO NOT EDIT) <ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>==
 
===Rheumatic Heart Disease (DO NOT EDIT) <ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>===
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Percutaneous or surgical MV commissurotomy is indicated when anatomically possible for treatment of severe [[Mitral stenosis|MS]], when clinically                                      indicated. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
|}
 
==Sources==
*2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease <ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>
 
==References==
{{reflist|2}}
 
{{Electrocardiography}}
{{Circulatory system pathology}}
 
[[Category:Cardiology]]
[[Category:Valvular heart disease]]
[[Category:Cardiac surgery]]
[[Category:Surgery]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 21:04, 22 July 2014